Giampaolo Trivellin
@gp83.bsky.social
Assistant Professor @ Humanitas University in Milan 🇮🇹. UniPD 🇮🇹, QMUL 🇬🇧, NIH 🇺🇸, Marie Curie 🇪🇺 alumnus. EYRC (@eyrc.bsky.social) coordinator 🇪🇺. Views are my own
Reposted by Giampaolo Trivellin
Following our latest Neuroendocrinology Watch by EYRC on LinkedIn:
DNA methylation profiling identifies high-risk SF1+ nonfunctioning PitNETs and predicts post-surgical regrowth.
Precision medicine is coming to PitNETs.
DNA methylation profiling identifies high-risk SF1+ nonfunctioning PitNETs and predicts post-surgical regrowth.
Precision medicine is coming to PitNETs.
January 21, 2026 at 9:22 PM
Following our latest Neuroendocrinology Watch by EYRC on LinkedIn:
DNA methylation profiling identifies high-risk SF1+ nonfunctioning PitNETs and predicts post-surgical regrowth.
Precision medicine is coming to PitNETs.
DNA methylation profiling identifies high-risk SF1+ nonfunctioning PitNETs and predicts post-surgical regrowth.
Precision medicine is coming to PitNETs.
Reposted by Giampaolo Trivellin
On behalf of the EYRC, Dr Mario Detomas interviewed Professor Mirjam Christ-Crain during the 9th ENEA Workshop held in Marseille, France, in December 2025.
Follow us on Linkedin for the full video!
Follow us on Linkedin for the full video!
February 19, 2026 at 9:44 AM
On behalf of the EYRC, Dr Mario Detomas interviewed Professor Mirjam Christ-Crain during the 9th ENEA Workshop held in Marseille, France, in December 2025.
Follow us on Linkedin for the full video!
Follow us on Linkedin for the full video!
Reposted by Giampaolo Trivellin
🧠 New EYRC Literature Review out now!
This time: a large RCT on targeted correction of chronic hyponatremia.
Read the summary on LinkedIn 👇
This time: a large RCT on targeted correction of chronic hyponatremia.
Read the summary on LinkedIn 👇
March 13, 2026 at 5:00 PM
🧠 New EYRC Literature Review out now!
This time: a large RCT on targeted correction of chronic hyponatremia.
Read the summary on LinkedIn 👇
This time: a large RCT on targeted correction of chronic hyponatremia.
Read the summary on LinkedIn 👇
Reposted by Giampaolo Trivellin
🚨 Neuroendocrinology Watch by EYRC!
This week, we highlight a novel retrospective cohort study exploring CXCR4-targeted imaging in Cushing’s disease.
For more information => Visit our LinkedIn page
This week, we highlight a novel retrospective cohort study exploring CXCR4-targeted imaging in Cushing’s disease.
For more information => Visit our LinkedIn page
March 31, 2026 at 1:24 PM
🚨 Neuroendocrinology Watch by EYRC!
This week, we highlight a novel retrospective cohort study exploring CXCR4-targeted imaging in Cushing’s disease.
For more information => Visit our LinkedIn page
This week, we highlight a novel retrospective cohort study exploring CXCR4-targeted imaging in Cushing’s disease.
For more information => Visit our LinkedIn page
Reposted by Giampaolo Trivellin
🚨 Neuroendocrinology Watch by EYRC!
This week, we highlight a single-nucleus multi-omics study of non-functioning pituitary adenomas (NFPAs), exploring their epigenetic landscape, gene regulatory modules, and tumor microenvironment.
=> Visit our Linkedin page for more details
This week, we highlight a single-nucleus multi-omics study of non-functioning pituitary adenomas (NFPAs), exploring their epigenetic landscape, gene regulatory modules, and tumor microenvironment.
=> Visit our Linkedin page for more details
April 4, 2026 at 10:59 AM
🚨 Neuroendocrinology Watch by EYRC!
This week, we highlight a single-nucleus multi-omics study of non-functioning pituitary adenomas (NFPAs), exploring their epigenetic landscape, gene regulatory modules, and tumor microenvironment.
=> Visit our Linkedin page for more details
This week, we highlight a single-nucleus multi-omics study of non-functioning pituitary adenomas (NFPAs), exploring their epigenetic landscape, gene regulatory modules, and tumor microenvironment.
=> Visit our Linkedin page for more details
Reposted by Giampaolo Trivellin
🧠 Neuroendocrinology Watch by EYRC!
Immune checkpoint inhibitors (ICIs) have transformed oncology — but they come with a price: immune-related endocrine adverse events, including pituitary dysfunction.
=> More on LinkedIn
Immune checkpoint inhibitors (ICIs) have transformed oncology — but they come with a price: immune-related endocrine adverse events, including pituitary dysfunction.
=> More on LinkedIn
April 17, 2026 at 3:27 PM
🧠 Neuroendocrinology Watch by EYRC!
Immune checkpoint inhibitors (ICIs) have transformed oncology — but they come with a price: immune-related endocrine adverse events, including pituitary dysfunction.
=> More on LinkedIn
Immune checkpoint inhibitors (ICIs) have transformed oncology — but they come with a price: immune-related endocrine adverse events, including pituitary dysfunction.
=> More on LinkedIn
As a current member of the EJE Rising Stars Reviewer Board, I can highly recommend this mentorship programme!
Applications are now open for the 2026–2028 cohort. Don’t miss this opportunity!
⏰ Deadline: 16 Jan 2026
#Endocrinology #AcademicPublishing #AcademicCareers #PeerReview #Mentorship #ECR
Applications are now open for the 2026–2028 cohort. Don’t miss this opportunity!
⏰ Deadline: 16 Jan 2026
#Endocrinology #AcademicPublishing #AcademicCareers #PeerReview #Mentorship #ECR
EJE Rising Stars Reviewer Board and Mentorship Programme - now open for applications!
Apply now 👉 www.ese-hormones.org/about-us/gov...
Deadline: Friday 16 January, 2026
Apply now 👉 www.ese-hormones.org/about-us/gov...
Deadline: Friday 16 January, 2026
January 8, 2026 at 3:37 PM
As a current member of the EJE Rising Stars Reviewer Board, I can highly recommend this mentorship programme!
Applications are now open for the 2026–2028 cohort. Don’t miss this opportunity!
⏰ Deadline: 16 Jan 2026
#Endocrinology #AcademicPublishing #AcademicCareers #PeerReview #Mentorship #ECR
Applications are now open for the 2026–2028 cohort. Don’t miss this opportunity!
⏰ Deadline: 16 Jan 2026
#Endocrinology #AcademicPublishing #AcademicCareers #PeerReview #Mentorship #ECR
Reposted by Giampaolo Trivellin
What a kickoff! 🎉 Day 1️⃣ of #EYES2025 in Milan was buzzing with energy, ideas, and networking.
🌟 Inspiring plenary lecture by Prof. Stratakis
🤝 Lively joint session with EYRC
🧪 Brilliant talks & posters from our ECIs
Day 2️⃣ — we’re ready! 🌱
@esendocrinology.bsky.social @ksaravinovska.bsky.social
🌟 Inspiring plenary lecture by Prof. Stratakis
🤝 Lively joint session with EYRC
🧪 Brilliant talks & posters from our ECIs
Day 2️⃣ — we’re ready! 🌱
@esendocrinology.bsky.social @ksaravinovska.bsky.social
September 27, 2025 at 2:04 PM
What a kickoff! 🎉 Day 1️⃣ of #EYES2025 in Milan was buzzing with energy, ideas, and networking.
🌟 Inspiring plenary lecture by Prof. Stratakis
🤝 Lively joint session with EYRC
🧪 Brilliant talks & posters from our ECIs
Day 2️⃣ — we’re ready! 🌱
@esendocrinology.bsky.social @ksaravinovska.bsky.social
🌟 Inspiring plenary lecture by Prof. Stratakis
🤝 Lively joint session with EYRC
🧪 Brilliant talks & posters from our ECIs
Day 2️⃣ — we’re ready! 🌱
@esendocrinology.bsky.social @ksaravinovska.bsky.social
Reposted by Giampaolo Trivellin
Dont miss the EYRC Session at the ENEA Workshop 2025 | Marseille, France 🇫🇷
Workshop Dates: 3–5 December 2025
More on LinkedIn: @enea-young-researcher-committee
Workshop Dates: 3–5 December 2025
More on LinkedIn: @enea-young-researcher-committee
August 22, 2025 at 12:20 PM
Dont miss the EYRC Session at the ENEA Workshop 2025 | Marseille, France 🇫🇷
Workshop Dates: 3–5 December 2025
More on LinkedIn: @enea-young-researcher-committee
Workshop Dates: 3–5 December 2025
More on LinkedIn: @enea-young-researcher-committee
Reposted by Giampaolo Trivellin
📢 Call for Abstracts – #ENEAWorkshop2025 🇫🇷
📅 3–5 Dec | Marseille
Theme: Changing the Paradigms – Translational Approach in Pituitary Tumors
📌 Deadline: 15 Sept 2025
✍️ Max 300 words | <41y = YIA eligible
📩 [email protected]
🔗 lnkd.in/e4yUiGZ9
📅 3–5 Dec | Marseille
Theme: Changing the Paradigms – Translational Approach in Pituitary Tumors
📌 Deadline: 15 Sept 2025
✍️ Max 300 words | <41y = YIA eligible
📩 [email protected]
🔗 lnkd.in/e4yUiGZ9
September 9, 2025 at 7:51 AM
📢 Call for Abstracts – #ENEAWorkshop2025 🇫🇷
📅 3–5 Dec | Marseille
Theme: Changing the Paradigms – Translational Approach in Pituitary Tumors
📌 Deadline: 15 Sept 2025
✍️ Max 300 words | <41y = YIA eligible
📩 [email protected]
🔗 lnkd.in/e4yUiGZ9
📅 3–5 Dec | Marseille
Theme: Changing the Paradigms – Translational Approach in Pituitary Tumors
📌 Deadline: 15 Sept 2025
✍️ Max 300 words | <41y = YIA eligible
📩 [email protected]
🔗 lnkd.in/e4yUiGZ9
Reposted by Giampaolo Trivellin
🥳 Happy to share the results of an ongoing work in which we are applying POSTRE (our tool for SV interpretation github.com/vicsanga/Pos...) to better comprehend the cause of X-LAG tumors, a pituitary disorder responsible for an overgrowth condition 🧬. Preprint: www.medrxiv.org/content/10.1...
1/3
1/3
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE
Background Structural variants (SVs) that disrupt topologically associating domains (TADs) can cause disease by rewiring enhancer-promoter interactions. Duplications involving GPR101 are known to caus...
www.medrxiv.org
July 10, 2025 at 10:11 PM
🥳 Happy to share the results of an ongoing work in which we are applying POSTRE (our tool for SV interpretation github.com/vicsanga/Pos...) to better comprehend the cause of X-LAG tumors, a pituitary disorder responsible for an overgrowth condition 🧬. Preprint: www.medrxiv.org/content/10.1...
1/3
1/3
Reposted by Giampaolo Trivellin
🧵1/3
Our new preprint is out! Proud to have contributed to this collaborative study. We identified the enhancer cluster responsible for GPR101 overexpression in X-linked acrogigantism (X-LAG) - a key step toward understanding this rare pituitary disorder 🧠🧬
🔗 www.medrxiv.org/content/10.1...
Our new preprint is out! Proud to have contributed to this collaborative study. We identified the enhancer cluster responsible for GPR101 overexpression in X-linked acrogigantism (X-LAG) - a key step toward understanding this rare pituitary disorder 🧠🧬
🔗 www.medrxiv.org/content/10.1...
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE
Background Structural variants (SVs) that disrupt topologically associating domains (TADs) can cause disease by rewiring enhancer-promoter interactions. Duplications involving GPR101 are known to caus...
www.medrxiv.org
July 9, 2025 at 1:47 PM
🧵1/3
Our new preprint is out! Proud to have contributed to this collaborative study. We identified the enhancer cluster responsible for GPR101 overexpression in X-linked acrogigantism (X-LAG) - a key step toward understanding this rare pituitary disorder 🧠🧬
🔗 www.medrxiv.org/content/10.1...
Our new preprint is out! Proud to have contributed to this collaborative study. We identified the enhancer cluster responsible for GPR101 overexpression in X-linked acrogigantism (X-LAG) - a key step toward understanding this rare pituitary disorder 🧠🧬
🔗 www.medrxiv.org/content/10.1...
Reposted by Giampaolo Trivellin
📣 Thrilled to announce our next speaker for the EYES Annual Meeting in Milan – Prof. Constantine Stratakis!
💡 Register & submit your abstract! ⏳
🇮🇹 Join us in Milan!
@esendocrinology.bsky.social @ksaravinovska.bsky.social
💡 Register & submit your abstract! ⏳
🇮🇹 Join us in Milan!
@esendocrinology.bsky.social @ksaravinovska.bsky.social
June 9, 2025 at 2:35 PM
📣 Thrilled to announce our next speaker for the EYES Annual Meeting in Milan – Prof. Constantine Stratakis!
💡 Register & submit your abstract! ⏳
🇮🇹 Join us in Milan!
@esendocrinology.bsky.social @ksaravinovska.bsky.social
💡 Register & submit your abstract! ⏳
🇮🇹 Join us in Milan!
@esendocrinology.bsky.social @ksaravinovska.bsky.social
Reposted by Giampaolo Trivellin
Delighted & excited to share our latest preprint on non-canonical enhancers in human pluripotent stem cells, the result of a fantastic and fun collaboration with @guenesdoganlab.bsky.social:
www.biorxiv.org/content/10.1...
🧵 below
www.biorxiv.org/content/10.1...
🧵 below
Non-canonical enhancers control gene expression and cell fate in human pluripotent stem cells
Enhancers are key gene regulatory elements that ensure the precise spatiotemporal execution of developmental gene expression programmes. However recent findings indicate that approaches to identify en...
www.biorxiv.org
June 2, 2025 at 11:26 PM
Delighted & excited to share our latest preprint on non-canonical enhancers in human pluripotent stem cells, the result of a fantastic and fun collaboration with @guenesdoganlab.bsky.social:
www.biorxiv.org/content/10.1...
🧵 below
www.biorxiv.org/content/10.1...
🧵 below
Reposted by Giampaolo Trivellin
High prevalence of deleterious germline variants in cancer risk genes among subjects with young-onset, sporadic pituitary macroadenomas https://www.medrxiv.org/content/10.1101/2025.05.15.25327006v1
May 17, 2025 at 12:57 AM
High prevalence of deleterious germline variants in cancer risk genes among subjects with young-onset, sporadic pituitary macroadenomas https://www.medrxiv.org/content/10.1101/2025.05.15.25327006v1
Reposted by Giampaolo Trivellin
🚨 New Neuroendo Watch by EYRC – Highlight Alert! 🚨
We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. 🧪🧠
Full post with takeaways on our LinkedIn page:
www.linkedin.com/company/enea-young-researcher-committee
We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. 🧪🧠
Full post with takeaways on our LinkedIn page:
www.linkedin.com/company/enea-young-researcher-committee
May 6, 2025 at 4:26 PM
🚨 New Neuroendo Watch by EYRC – Highlight Alert! 🚨
We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. 🧪🧠
Full post with takeaways on our LinkedIn page:
www.linkedin.com/company/enea-young-researcher-committee
We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. 🧪🧠
Full post with takeaways on our LinkedIn page:
www.linkedin.com/company/enea-young-researcher-committee
Reposted by Giampaolo Trivellin
April 7, 2025 at 5:01 PM
Reposted by Giampaolo Trivellin
THREAD
The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter
In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.
By quite a lot.
Release the Kraken...
#AcademicSky #HigherEd #Altmetrics
1/11
The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter
In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.
By quite a lot.
Release the Kraken...
#AcademicSky #HigherEd #Altmetrics
1/11
March 27, 2025 at 5:22 PM
THREAD
The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter
In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.
By quite a lot.
Release the Kraken...
#AcademicSky #HigherEd #Altmetrics
1/11
The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter
In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.
By quite a lot.
Release the Kraken...
#AcademicSky #HigherEd #Altmetrics
1/11
Reposted by Giampaolo Trivellin
🚀 EYRC Neuroendo Watch
We highlight a study in Endocrine, offering new insights into MEN5: tinyurl.com/25n94ac3
📌First reported case of pit-gigantism linked to a germline MAX mutation
📌Myelolipoma as a new disease association in MEN5
📌Expansion of the phenotype beyond PPGLs
By @gp83.bsky.social
We highlight a study in Endocrine, offering new insights into MEN5: tinyurl.com/25n94ac3
📌First reported case of pit-gigantism linked to a germline MAX mutation
📌Myelolipoma as a new disease association in MEN5
📌Expansion of the phenotype beyond PPGLs
By @gp83.bsky.social
March 10, 2025 at 3:53 PM
🚀 EYRC Neuroendo Watch
We highlight a study in Endocrine, offering new insights into MEN5: tinyurl.com/25n94ac3
📌First reported case of pit-gigantism linked to a germline MAX mutation
📌Myelolipoma as a new disease association in MEN5
📌Expansion of the phenotype beyond PPGLs
By @gp83.bsky.social
We highlight a study in Endocrine, offering new insights into MEN5: tinyurl.com/25n94ac3
📌First reported case of pit-gigantism linked to a germline MAX mutation
📌Myelolipoma as a new disease association in MEN5
📌Expansion of the phenotype beyond PPGLs
By @gp83.bsky.social
Reposted by Giampaolo Trivellin
Welcome to the ENEA Young Researchers Committee (EYRC), a subcommittee of ENEA dedicated to supporting early career scientists in neuroendocrinology.
✨ Our Mission:
🔹 Strengthening ENEA’s visibility
🔹 Representing early career researchers
🔹 Organizing symposia & workshops
🔹 And much more ...
✨ Our Mission:
🔹 Strengthening ENEA’s visibility
🔹 Representing early career researchers
🔹 Organizing symposia & workshops
🔹 And much more ...
February 16, 2025 at 4:12 PM
Welcome to the ENEA Young Researchers Committee (EYRC), a subcommittee of ENEA dedicated to supporting early career scientists in neuroendocrinology.
✨ Our Mission:
🔹 Strengthening ENEA’s visibility
🔹 Representing early career researchers
🔹 Organizing symposia & workshops
🔹 And much more ...
✨ Our Mission:
🔹 Strengthening ENEA’s visibility
🔹 Representing early career researchers
🔹 Organizing symposia & workshops
🔹 And much more ...
When your weekend’s pancake turns out to look something like a #zebrafish embryo during the gastrula period 🤣
@zebrafishrock.bsky.social
@zebrafishrock.bsky.social
February 3, 2025 at 9:57 PM
When your weekend’s pancake turns out to look something like a #zebrafish embryo during the gastrula period 🤣
@zebrafishrock.bsky.social
@zebrafishrock.bsky.social
Why Is Every Human Being Riddled With Genetic Errors? www.smithsonianmag.com/science-natu...
Why Is Every Human Being Riddled With Genetic Errors?
Your body is a collection of cells carrying thousands of genetic mistakes accrued over a lifetime—many harmless, some bad and at least a few that may be good for you
www.smithsonianmag.com
January 18, 2025 at 10:10 AM
Why Is Every Human Being Riddled With Genetic Errors? www.smithsonianmag.com/science-natu...